UnitedHealth Cancer Care Pilot Reduced Overall Costs Despite Higher Drug Spending
This article was originally published in The Pink Sheet Daily
Executive Summary
The bundled payment pilot program resulted in a 34% decrease in overall cancer treatment costs among participating medical centers despite a 179% increase in drug spending, according to results released July 8.
You may also be interested in...
UnitedHealth Moving, Slowly, Toward More Value-Based Drug Contracts
Insurer plans to execute more value-based contracts in next two years, but they will be pilot projects layered on top of existing rebate contracts.
Aetna Cancer Pathways Program Aims For 'Value-Based' Prescribing
“For many malignancies, there is no ‘best treatment’ but there may be tremendous differences in cost,” Aetna National Medical Director, Oncology Solutions Michael Kolodziej says.
Biosimilars Add “Urgency” To Medicare Payment Reforms – MedPAC Commissioner
Developing alternatives to the ASP-based reimbursement system for Medicare Part B drugs may become increasingly important to ensure the program will benefit from lower-cost biosimilars, Georgetown’s Jack Hoadley points out.